AZD2389 is an effective and orally active FAP inhibitor that improves histological fibrosis and increases intact alpha2-AP, suitable for studying metabolic dysfunction-associated steatohepatitis.
Molecular Weight:
411.48
Purity:
97.89%
CAS Number:
[2791472-12-1]
Formula:
C20H21N5O3S
Target:
Immunology/Inflammation related
T206169
* VAT and and shipping costs not included. Errors and price changes excepted
